Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Northbound Flows: Shenzhen Inovance, Nari Technology

Northbound Flows: Big Sell on CATL After May Holiday

Northbound Flows: Moutai, Zijin, Great Wall Motor

Northbound Flows: Moutai, CSCC, Beijing Oriental Yuhong, Sungrow

Northbound Flows: Sungrow Power, Hengrui, Ganfeng, Cosco Shipping

Northbound Flows: CATL, Moutai, Yunnan Energy New Material, Aier Eye

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyze the weekly Shanghai/Shenzhen northbound Connect flows with our data engine.</li>
<li>We highlight top inflows including CATL, Moutai, China Yangtze Power.</li>
<li>We highlight top outflows including China Merchants Bank, East Money, and Sungrow.</li>
</ul>


We analyze the weekly Shanghai/Shenzhen northbound Connect flows with our data engine.
We highlight top inflows including CATL, Moutai, China Yangtze Power.
We highlight top outflows including China Merchants Bank, East Money, and Sungrow.


Contemporary Amperex Technology (CATL) (300750 CH)

Northbound Flows: CMB Big Sell After CEO Scandal